Thermo Fisher Scientific obtains CE Mark for NGS, Dx workflows

By LabPulse.com staff writers

June 15, 2022 -- Thermo Fisher Scientific has received a CE-IVD Mark under the In Vitro Diagnostic Medical Devices Directive (IVDD) for its Ion Torrent Reporter Software Aneuploidy Dx Workflows for the detection of aneuploidies.

According to Thermo Fisher, the Ion Torrent Reporter Software Aneuploidy Dx Workflows provide qualitative determination of aneuploidies, including the trisomy status of chromosome 21, in genomic DNA derived from human cells using next-generation sequencing (NGS).

The detection of aneuploidies is intended for screening embryos to improve in vitro fertilization (IVF) outcomes. The workflows are suitable for use by genetic testing labs, IVF clinics, and hospital systems conducting preimplantation genetic testing, Thermo Fisher added.

FDA clears Thermo Fisher autoimmune disease tests
Thermo Fisher Scientific on Thursday announced that the U.S. Food and Drug Administration (FDA) has cleared its EliA RNA Pol III and EliA Rib-P blood...
Thermo Fisher launching IVDR-compliant RT-PCR system
Thermo Fisher Scientific on Tuesday announced that it is offering a new version of its Applied Biosystems QuantStudio 5 Dx Real-Time PCR System that is...
Thermo Fisher launches new NGS platform
Thermo Fisher Scientific has launched Ion Torrent Genexus Dx Integrated Sequencer, an automated next-generation sequencing (NGS) platform.
Thermo Fisher joins effort to identify SARS-CoV-2 variants
Thermo Fisher Scientific announced it is supporting a U.S. program to speed up the identification of SARS-CoV-2 variants.
Thermo Fisher develops new viral transport medium
Thermo Fisher Scientific's new viral inactivation medium with a swab for use in in vitro diagnostic testing for SARS-CoV-2 is available in Europe.

Copyright © 2022 LabPulse.com

Last Updated mp 6/15/2022 9:15:51 AM